← Back to headlines
Eli Lilly to Acquire Merida Biosciences for Up to $2.88 Billion
Eli Lilly has agreed to purchase biotech firm Merida Biosciences in a cash deal valued at up to $2.88 billion. The acquisition is designed to accelerate the development of novel therapies targeting serious autoimmune and allergic conditions.
31 Aug, 10:48 — 31 Aug, 12:16
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (59/100)7 sources33/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left1
Left (1)
cnbc
Center3
Center (3)
Reutersmorningstarinvesting-com
Right3
Right (3)
wsjBarron'sseeking-alpha
Far R
Geographic diversity— 2 regions9/34
US6Intl1
Sources
Showing 7 of 7 sources
ReutersVery High10h ago
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push - Reuters
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push Reuters
Read full article →wsjHigh11h ago
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion - WSJ
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion WSJ
Read full article →cnbcMostly Factual11h ago
Eli Lilly to buy Merida Biosciences in deal worth up to $2.88 billion
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
Read full article →Barron'sHigh11h ago
Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. - Barron's
Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. Barron's
Read full article →morningstar11h ago
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases - Morningstar
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases Morningstar
Read full article →seeking-alphaMixed11h ago
Lilly to buy Merida Biosciences for up to $2.875B in cash
Read full article →investing-com11h ago
Lilly to acquire Merida Biosciences for up to $2.875 billion
By Investing.com
Read full article →Coverage Timeline
First report: investing-com · 31 Aug, 10:48|Full coverage: 7 · 1h|Window: 1h
Left-leaningCenterRight-leaning
